Clarity

  CPDA

 A Carcinogenic Pathway Detoxifier

PRODUCT APPLICATION

NUERO AND VASCULAR

Neurological application. CPDA is a complex formulation of amino acids and alkaloids in a liquid delivery system. The formula is designed to be pulled through the blood brain barrier. (The blood-brain barrier (BBB) is formed by brain endothelial cells lining the cerebral microvasculature, and is an important mechanism for protecting the brain from fluctuations in plasma composition, and from circulating agents such as neurotransmitters and xenobiotics capable of disturbing neural function.)  The CPDA formulation is a combination of extraction, binding, and new combination of matter patented and patent pending.

The neurological application of CPDA triggers the production of all the necessary neurological chemicals for healthy brain function including a detoxification produced by the new combination of amino acids and alkaloids. No other company, or research group, has been able to groove bind molecules together for neurological applications.  The core molecular structure of all components is not altered.  By the groove binding of the molecular structure of the amino acids and alkaloids, in combination, CPDA generates neurological, and biological responses never before seen.

Medical Definitions

Groove Binding:                           

The groove binding of DNA is the same type of binding in food through the digestive system.  Dr. Stella’s formula maintains the separate integrity of each molecular structure.

Vascular and Neuro Flooding:

Vascular and Neuro flooding (blood) in the brain occurs in migraines now appears to occur and to be caused by impact to the head in sports. (concussion “Mayo Clinic caused by blow to the head or shaking”)

Synapse: a junction between two nerve cells (neurons), consisting of a minute gap across which impulses pass by diffusion of a neurotransmitter

How do amyloid plaques cause Alzheimer’s?

Scientists at the Stanford University School of Medicine have shown how a protein fragment known as beta-amyloid, strongly implicated in Alzheimer’s disease, begins destroying synapses before it clumps into plaques that lead to nerve cell death.